Wilson disease is a genetic condition that causes copper to build up in the liver, brain, and eyes. Many people with Wilson disease first notice fatigue, jaundice, tremor, mood changes, or trouble with school or work. It is lifelong and usually appears in late childhood to early adulthood, but younger and older ages occur. Without treatment, Wilson disease can lead to liver failure or neurologic disability, and in severe cases it can be life-threatening. Treatment is long-term and typically includes copper-chelating medicines, zinc to block absorption, and a low-copper diet, and liver transplant is considered if damage is advanced.
Overview
Wilson diseaseSymptoms
Wilson disease can cause tiredness, jaundice, belly pain or swelling, and easy bruising from liver trouble. Brain involvement may bring tremor, stiff movements, slurred speech, clumsiness, or mood changes. Early symptoms of Wilson disease start in adolescence or young adulthood.
Outlook and prognosis
Many people with Wilson disease do well long term when treatment starts early and continues for life. Medicines that remove or block copper can reverse liver and neurologic symptoms and prevent complications. Delayed diagnosis raises risks, but specialist care improves outcomes.
Causes and risk factors
Wilson disease results from inheriting two faulty copies of a copper‑transport gene. Risk is highest for children of two carriers, affected siblings, and families with related parents. Lifestyle doesn’t cause it, though nutrition and illnesses can influence when symptoms start.
Genetic influences
Genetics is central in Wilson disease. It’s an inherited condition caused by changes in the ATP7B gene; you must receive one altered copy from each parent. Variations in this gene influence age at onset, symptoms, and response to treatment.
Diagnosis
Doctors suspect Wilson disease from clinical features such as liver problems, movement changes, or eye rings. Confirmation uses blood and urine copper tests, eye exam, liver imaging or biopsy, and ATP7B genetic tests. Genetic diagnosis of Wilson disease is common.
Treatment and drugs
Wilson disease treatment focuses on removing extra copper and keeping levels steady. Doctors often start with medicines that help the body clear copper, then continue long term with maintenance therapy and a low-copper diet. Regular blood tests, eye exams, and dose adjustments guide care over time.
Symptoms
Day to day, Wilson disease can show up in small ways that build over time—feeling unusually tired, shaky hands when pouring coffee, or moods that seem out of character. Symptoms vary from person to person and can change over time. People may notice early features of Wilson disease in the liver, brain, eyes, or mental health, and they can range from very mild to more noticeable.
Energy feels low and everyday tasks take more effort. This can be one of the earliest features. Rest may not fully restore stamina.
Yellowing of the skin or eyes and itchy skin can signal liver strain. Urine may look dark, while stools can become pale or gray. These changes may come and go at first.
Puffy ankles or a swollen abdomen can develop from fluid buildup. Shoes or waistbands may feel tighter by evening. This often reflects ongoing liver stress.
Hands may shake when holding a cup or writing. Stress and fatigue can make it more noticeable. This is common when Wilson disease affects movement areas of the brain.
How people usually first notice Wilson disease?
Many first notice Wilson disease when unexplained symptoms stack up: tiredness that won’t lift, yellowing of the eyes or skin, belly pain or swelling, or tremors and clumsy movements that seem out of character. Doctors are often tipped off by abnormal liver tests, anemia, or a telltale copper-colored ring at the edge of the cornea (Kayser-Fleischer ring) during an eye exam, which together raise suspicion for copper buildup. For children and teens, the first signs of Wilson disease may show up as early liver problems or changes in school performance, mood, or coordination, prompting tests that confirm the diagnosis.
Types of Wilson disease
Wilson disease has a few recognized clinical patterns that reflect where copper builds up most and how early it’s found. Clinicians often describe them in these categories: liver-predominant, neurologic-predominant, and mixed forms, plus a silent or presymptomatic phase found through screening. Symptoms don’t always look the same for everyone. Understanding these types of Wilson disease can help explain why one person has mainly liver issues while another has movement or mood changes.
Hepatic-predominant
Liver problems are front and center, ranging from fatigue and jaundice to enlarged liver or swelling. This type often appears in children or teens and can include hepatitis-like flares or acute liver failure. Early symptoms of Wilson disease in this group may be mistaken for common liver conditions.
Neurologic-predominant
Movement and coordination changes lead the picture, such as tremor, stiffness, slowed speech, or poor balance. Thinking, mood, or behavior shifts—like depression, anxiety, or irritability—may show up too. Eye findings such as Kayser–Fleischer rings are common in this type.
Mixed hepatic-neurologic
Liver and nervous system features appear together, sometimes at the same time and sometimes in sequence. People may have abnormal liver tests plus tremor or speech changes. This blend can develop at any age from adolescence to adulthood.
Presymptomatic/silent
No clear symptoms yet, but abnormal copper studies or gene testing identify risk before damage is obvious. This is often found through family screening of relatives of someone diagnosed. Starting treatment early can prevent liver or neurologic complications.
What genetics can tell you about symptoms
Some people with ATP7B gene variants develop tiredness, yellowing eyes or skin, belly pain, or shaky movements because copper builds up in the liver and brain instead of being carried out. Certain variants cause earlier, more severe liver symptoms, while others lean toward neurological changes.
Causes and risk factors
Wilson disease is caused by changes in the ATP7B gene that reduce the body’s ability to move copper out of the liver. It is inherited in an autosomal recessive pattern, meaning you need two changed copies, one from each parent. Family history is the main risk, and each full sibling of someone with Wilson disease has about a 25% chance of having it too. High copper in water or supplements can worsen copper buildup, and liver stress from infections, heavy alcohol, or pregnancy may bring on symptoms. Knowing your family history is a good first step.
Environmental and biological risk factors
Here’s what research says about environmental and biological risk factors for Wilson disease. Doctors often group risks into internal (biological) and external (environmental). For this condition, no everyday exposure has been proven to increase the chance that it occurs. These factors do not predict early symptoms of Wilson disease; they relate only to how likely it is to occur.
Drinking water or food with more copper does not cause Wilson disease. It does not raise the chance of the condition occurring. Very high copper can cause separate copper toxicity in anyone, which is different from Wilson disease.
Having an older mother or father has not been shown to increase the chance of Wilson disease. The likelihood does not appear to change with age at conception.
Common infections, routine medicines, or typical environmental exposures during pregnancy have not been linked to a higher risk of Wilson disease. No specific toxin in pregnancy has been confirmed to cause this condition.
Prematurity, low or high birth weight, and mode of delivery are not known to change the chance of Wilson disease. Research has not identified reliable birth-related risk factors.
Genetic risk factors
Genetic patterns in families can raise the chance that Wilson disease will develop. Some risk factors are inherited through our genes. This section explains the genetic causes of Wilson disease and who may be at higher inherited risk.
ATP7B gene changes: Wilson disease happens when both copies of the ATP7B gene have disease-causing changes. These changes block copper handling, leading to buildup over time. More than 500 different ATP7B changes have been found worldwide.
Autosomal recessive: You need two nonworking copies of ATP7B, one from each parent, to develop Wilson disease. People with one changed copy are carriers and usually healthy. This pattern affects all sexes equally.
Two carrier parents: If both parents are carriers, each pregnancy has a 25% (1 in 4) chance of a child with Wilson disease. There is also a 50% (1 in 2) chance the child will be a carrier. The remaining 25% (1 in 4) will inherit no ATP7B changes.
Sibling risk: Full brothers and sisters of someone with Wilson disease have a higher chance of also being affected. Until tested, each sibling has up to a 25% (1 in 4) chance if both parents are carriers. Testing can clarify who is affected or a carrier.
Family history: Having a close relative with known ATP7B changes raises your chance of being a carrier or having Wilson disease. Genetic counseling can help map who in the family may be at risk. Testing targeted to the family’s known changes is often most informative.
Ancestry patterns: In some regions and ancestries, a few ATP7B changes are more common. This can increase carrier rates and the chance two carriers meet. People from these groups may have higher inherited risk of Wilson disease.
Related parents: When parents are related by blood, they are more likely to carry the same ATP7B change. This increases the chance of a child with Wilson disease. The exact risk depends on how closely related the parents are.
Two different changes: Many people with Wilson disease carry two different ATP7B changes, one on each gene copy. This is common and affects how genetic testing is interpreted. It does not necessarily predict how severe the condition will be.
Chance and timing: Most people with two ATP7B changes will develop Wilson disease, but the age it appears and which organs are affected vary widely. Even in the same family, one person may be diagnosed in childhood and another in adulthood. Shared changes can lead to different experiences.
New changes rare: Wilson disease is usually inherited from carrier parents rather than caused by a brand-new ATP7B change. New (de novo) changes appear to be uncommon. A genetics professional can discuss rare scenarios.
Testing confirms risk: Genetic testing for ATP7B changes can confirm the diagnosis and define carrier status in relatives. Finding the exact family changes allows accurate testing for siblings and future pregnancies. Results can guide options for family planning.
Lifestyle risk factors
Wilson disease is a genetic condition; lifestyle habits do not cause it, but they can influence symptoms, treatment success, and the risk of complications. Understanding how lifestyle affects Wilson disease helps you make daily choices that support your liver and nervous system. Below are practical lifestyle risk factors for Wilson disease and how to adjust them to reduce copper burden and protect organ function.
Organ meats, shellfish, nuts, chocolate, and mushrooms are rich in copper and can add to the body’s copper load. Choosing lower‑copper alternatives and avoiding copper‑fortified products can help control symptoms and support chelation.
Multivitamins or minerals that contain copper can counteract treatment and raise copper levels. Selecting copper‑free products and checking labels reduces the chance of worsening liver or neurologic issues.
Alcohol accelerates liver inflammation and scarring in people with Wilson disease. Avoiding alcohol lowers the risk of hepatitis flares, fluid buildup, and portal hypertension.
A salty diet can worsen swelling and ascites when the liver is affected. Limiting sodium helps control fluid retention and eases breathlessness and abdominal discomfort.
Risk prevention
Wilson disease can’t be prevented in the traditional sense because it’s inherited, but complications can often be avoided with early detection and steady treatment. Screenings and check-ups are part of prevention too. Knowing early symptoms of Wilson disease—like tiredness, yellowing of the eyes or skin, mood changes, or shaky hands—helps families seek testing sooner. Day to day, prevention means limiting copper exposure, protecting the liver, and sticking closely to medicines that control copper levels.
If someone in your family has Wilson disease, first‑degree relatives should be tested. Early diagnosis allows treatment before liver or brain problems build up.
Meeting with a genetics professional can explain inheritance and testing options. This helps plan for children and supports informed choices for relatives.
Take copper‑binding (chelation) medicines or zinc exactly as prescribed. Skipping doses can let copper rise and trigger liver or neurologic flare‑ups.
Zinc blocks copper absorption from food in Wilson disease. Staying on the correct dose and timing (often away from meals) helps keep copper down.
Transmission
Wilson disease is not contagious; it cannot be caught from others through air, touch, sex, or blood. It is passed down in families in a recessive pattern, known medically as autosomal recessive: a child must inherit two nonworking copies of the same gene—one from each parent—to develop Wilson disease. If both parents are healthy carriers, each pregnancy has a 25% (1 in 4) chance of Wilson disease, a 50% (1 in 2) chance the child will be a carrier, and a 25% chance of neither. Rarely, a new gene change happens for the first time in a child, but most cases come from carrier parents. Because of the genetic transmission of Wilson disease, close relatives—including siblings—should consider testing and counseling.
When to test your genes
Consider genetic testing if you have unexplained liver problems, low ceruloplasmin, eye rings from copper (Kayser–Fleischer), or neurologic symptoms—especially before age 40. It’s also recommended if a close relative has Wilson disease, since siblings have a 1 in 4 chance of being affected. Early diagnosis guides copper-lowering treatment and prevents organ damage.
Diagnosis
Wilson disease is typically identified by a mix of recognizable signs and targeted tests that confirm copper buildup in the body. The genetic diagnosis of Wilson disease usually combines clinical clues with lab results, eye findings, and, when needed, genetic testing. Getting a diagnosis is often a turning point toward answers and support.
Clinicians look for patterns such as fatigue, jaundice, tremor, mood changes, or trouble with coordination. A detailed family and health history can help point to inherited causes like Wilson disease. These findings guide which tests to run first.
An eye specialist checks for Kayser–Fleischer rings, thin brownish rings at the edge of the cornea caused by copper deposits. Finding these rings strongly supports a diagnosis of Wilson disease. The slit-lamp exam is quick and painless.
A simple blood test measures ceruloplasmin, a copper-carrying protein often low in Wilson disease. Liver enzymes and bilirubin may also be checked to look for liver stress. Low ceruloplasmin alone isn’t enough to confirm the condition.
A 24-hour urine collection measures how much copper the body is excreting. Elevated urinary copper supports Wilson disease, especially when symptoms or eye findings are present. This test can also help track response to treatment over time.
Stages of Wilson disease
Wilson disease does not have defined progression stages. Symptoms and organ involvement can vary widely—liver, brain, and eyes may be affected at different times—so it doesn’t follow a single, step-by-step pattern. Different tests may be suggested to help confirm the diagnosis and check how the liver and brain are doing. Doctors use blood and urine copper tests, an eye exam to look for copper rings, imaging or liver assessment, and sometimes genetic testing; this approach also helps make sense of early symptoms of Wilson disease.
Outlook and prognosis
Daily routines often adapt as Wilson disease is treated, shifting from frequent lab checks early on to steadier maintenance once copper levels come under control. With ongoing care, many people maintain good health for decades, including those who once had serious liver or neurologic symptoms. Doctors call this the prognosis—a medical word for likely outcomes. Without treatment, the condition can be life-threatening due to liver failure, severe infections, or heart and nervous system complications. With modern therapy started early, survival approaches that of people without Wilson disease, and the risk of needing a liver transplant drops significantly, though it isn’t zero.
Some people experience early symptoms of Wilson disease in their teens or twenties—fatigue, jaundice, shaky hands, mood changes—while others notice problems later in adulthood. The outlook is not the same for everyone, but people who begin chelation or zinc therapy before advanced liver scarring or major neurologic injury generally do best. If liver failure develops despite treatment, transplant can be lifesaving, and many return to active lives afterward. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. Skipping medicines, high-copper diets, or alcohol can trigger setbacks, while steady treatment, vaccines, and regular follow-up lower the chance of flare-ups.
Talk with your doctor about what your personal outlook might look like. Knowing what to expect can ease some of the worry. Genetic testing can sometimes provide more insight into prognosis, especially for families planning or for those with unusual features.
Long-term effects
Wilson disease can affect the liver, brain, eyes, blood, kidneys, bones, and heart over the long term. Long-term effects vary widely, and they depend on when the condition is found and how well treatment keeps copper under control. Early symptoms of Wilson disease may be subtle, but the long-term outlook is often good when care starts early and continues over time. Many people go to school, work, and family life with few limits once their copper levels are steadier.
Ongoing inflammation can scar the liver and reduce how well it works. This can lead to tiredness, swelling in the legs, and belly fluid build-up.
Advanced scarring can cause high pressure in the vein to the liver (portal hypertension). Over time this may bring enlarged spleen, varices, and a higher risk of bleeding.
In rare cases, the liver can fail suddenly or after years of damage. This can be life-threatening and may require urgent hospital care.
Copper in the brain can cause tremor, stiffness, slow movement, or unsteady walking. Some may notice clumsy handwriting or trouble with fine hand tasks.
How is it to live with Wilson disease?
Living with Wilson disease often means building routines around medicines that remove extra copper and keeping an eye on liver and neurologic health, even on days you feel well. Some notice fatigue, tremor, mood shifts, or trouble concentrating during flare-ups, which can make work, school, or driving harder until treatment is adjusted. Meals may take more planning to limit high-copper foods, and regular lab checks become part of life, but many regain stability and lead full lives once treatment is steady. Family and friends often play a key role—helping with reminders, appointments, and emotional support—while also getting screened themselves, since early detection in relatives can prevent serious problems.
Treatment and drugs
Wilson disease is treated by lowering and controlling the extra copper in your body to protect the liver, brain, and eyes. Treatment often starts with chelating medicines that bind copper so you can pass it out in urine; commonly used options include penicillamine or trientine, and a doctor may adjust your dose to balance benefits and side effects. Many people then switch to a maintenance plan with zinc salts, which block copper from being absorbed from food, and this long-term treatment is called maintenance therapy. For severe liver damage or liver failure, a liver transplant may be considered, which can be life-saving and correct the underlying copper handling. Alongside medical treatment, lifestyle choices play a role, including limiting high-copper foods and avoiding supplements that contain copper.
Non-drug treatment
Living with Wilson disease often means daily choices that protect your liver, brain, and energy. Alongside medicines, non-drug therapies can steady day-to-day life and help you stay active at home, work, or school. Support ranges from tailored nutrition to movement, mental health care, and planning for family testing. Early support can also ease stress if early symptoms of Wilson disease start to affect mood, speech, or coordination.
Limit high-copper foods like liver, shellfish, nuts, chocolate, and mushrooms. Choose grains, most fruits and vegetables, and lean proteins that are naturally lower in copper. A dietitian can personalize goals for growth, pregnancy, or sports.
Use tested water or certified filters if you have copper pipes, and avoid copper or unlined brass cookware. Flush cold tap water for several seconds before drinking or cooking. Do not take supplements that contain copper.
Alcohol strains the liver and can speed scarring. Staying alcohol-free helps protect liver recovery in Wilson disease. Ask about safer social options if cutting back feels difficult.
A registered dietitian can map out meals, label-reading, and restaurant strategies. They can help you meet protein and calorie needs if appetite is low or weight is changing. Plans adjust as labs and symptoms change.
Your genes may have an impact on how drugs work for you
Medicines for Wilson disease, like chelators and zinc, can work differently depending on genes that affect drug transport, metabolism, and copper handling. Genetic differences may change dose needs or side‑effect risk, so clinicians sometimes adjust therapy based on your response.
Pharmacological treatments
Medicines for Wilson disease aim to lower copper in the body and protect the liver and brain over the long run. Treatment usually starts with drugs that remove stored copper, then shifts to medicines that keep new copper from building up. Understanding early symptoms of Wilson disease can help time treatment decisions, but the options below focus on copper control. Not everyone responds to the same medication in the same way.
This long‑used medicine binds copper so your body can pass it out in urine. First-line medications are those doctors usually try first, based on safety, effectiveness, and guidelines. It needs regular blood and urine checks because side effects can include rash, low blood counts, or protein in the urine.
This is an alternative copper‑binding drug that many tolerate better than penicillamine. Dosing may be increased or lowered gradually to balance copper control and side effects. It can rarely worsen movement or speech symptoms at the start, so close follow‑up is important.
Zinc blocks copper absorption from food and is often used for maintenance therapy in Wilson disease after copper stores are lowered. Sometimes medicines are taken short-term (acute treatment), while others are used long-term (maintenance therapy). Taken on an empty stomach, zinc can upset the stomach, so timing and spacing from meals or other pills matter.
In some regions this copper‑binding agent may be available only through studies or special access, and it is not a standard first choice. It is being explored especially for people with prominent neurologic symptoms of Wilson disease.
Genetic influences
Changes in a single gene called ATP7B can lead to Wilson disease by disrupting how the body moves and clears copper, especially in the liver. It’s inherited in a recessive way: a child needs two altered copies—one from each parent—to develop Wilson disease. If both parents are carriers, each pregnancy has a 25% chance of a child with the condition, a 50% chance of a carrier, and a 25% chance of neither. A “carrier” means you hold the gene change but may not show symptoms. The age it starts and how severe it becomes can vary widely, even within the same family. Because copper buildup can be silent for years, understanding the family pattern can help catch early symptoms of Wilson disease before organ damage. DNA testing of the ATP7B gene and screening of siblings and close relatives can confirm the diagnosis, guide treatment, and point to who else may need monitoring.
Is Wilson disease genetic?
Genetics is central in Wilson disease. It’s an inherited condition caused by changes in the ATP7B gene; you must receive one altered copy from each parent. Variations in this gene influence age at onset, symptoms, and response to treatment.
Pharmacogenetics—how genetics influence drug effects
In Wilson disease, changes in the Wilson disease gene (ATP7B) confirm the diagnosis, but they rarely determine which medicine you’ll use or the exact dose. Doctors usually choose between copper‑binding drugs such as penicillamine or trientine and zinc therapy based on whether someone has liver or neurologic problems and on how advanced or early symptoms of Wilson disease are, rather than on a specific gene change. Not every difference in response is genetic, but factors like disease severity, copper levels, liver and kidney function, other medicines, and day‑to‑day adherence tend to drive outcomes and side effects. The common pharmacogenetic tests used for other medicines (for example, CYP enzyme panels) don’t currently guide treatment with penicillamine, trientine, or zinc. Research is ongoing into whether particular ATP7B variants relate to patterns of symptoms, but at present they aren’t used to predict who will respond better to one therapy over another. Genetic testing is still important for family screening and for confirming Wilson disease, while regular monitoring of copper balance helps your care team adjust treatment as your needs change.
Interactions with other conditions
Liver diseases like viral hepatitis, alcohol-related liver injury, or fatty liver can occur alongside Wilson disease and together speed up scarring, confuse lab results, and raise the risk of sudden worsening. Doctors call it a “comorbidity” when two conditions occur together. Neurologic or mental health conditions such as depression, anxiety, or movement disorders may also be present; some medicines used for mood or psychosis can intensify tremor or stiffness, so coordinating care helps prevent medication side effects from being mistaken for early symptoms of Wilson disease. Infections or physical stress can trigger hemolytic anemia in Wilson disease, which can make fatigue, jaundice, and shortness of breath worse than expected. Treatment can intersect with other illnesses too: penicillamine may unmask or worsen certain autoimmune problems (for example, a lupus‑like illness or myasthenia gravis), and kidney disease can change how safely chelators are used. If more than one specialist is involved, shared plans for monitoring copper levels, liver health, mental health, and medication interactions can lower the chance that one condition will exacerbate another.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described unusual patterns of jaundice, tremor, or behavior changes in young adults that puzzled families and doctors. A teenager who once kept up in school might start to struggle with concentration, develop shaky hands, or notice yellowing eyes. For many, this was first seen as separate problems of the liver, mood, or movement. Only later did medicine connect these clues to one underlying cause: Wilson disease.
First described in the medical literature as a disorder linking liver damage and neurological symptoms in the early 1900s, it was named after Dr. Samuel Alexander Kinnier Wilson. Initially understood only through symptoms, later work revealed a shared thread—excess copper building up in the body. As medical science evolved, doctors recognized that copper could quietly accumulate for years before signs appeared, which explained why some children seemed well until adolescence or early adulthood.
With each decade, the picture became clearer. In the mid-20th century, researchers identified telltale features like Kayser-Fleischer rings—copper-colored circles seen at the edge of the cornea—and low blood levels of a copper-carrying protein. These helped clinicians move from guesswork to more reliable diagnosis. Around the same time, families showed patterns that pointed to inheritance, where two carrier parents could have a child with Wilson disease, even if neither parent had symptoms.
Advances in genetics in the late 20th and early 21st centuries pinpointed changes in a specific gene that acts like a copper-transport “dimmer switch,” helping the body move copper into bile for removal. When that switch is faulty, copper builds up, first in the liver, then often in the brain and eyes. Genetic testing made family screening possible, so siblings could be checked before serious harm occurred. This shifted care toward earlier detection and prevention.
Treatment history changed the outlook dramatically. Before reliable therapy, many with Wilson disease developed severe liver disease or disabling movement symptoms. The introduction of copper-chelating medicines and zinc therapy allowed copper levels to be lowered or blocked from absorption, turning a once-devastating condition into one that can usually be managed long term. Liver transplantation later offered a life‑saving option for those with acute liver failure or advanced cirrhosis.
Over time, the way the condition has been understood has changed, and so has the care people receive. Today, clinicians combine eye exams, blood and urine tests, liver imaging or biopsy, and genetic testing to confirm Wilson disease, often before symptoms become severe. Knowing the condition’s history helps explain why doctors look beyond the liver to the brain and eyes, and why relatives are often offered screening. Each step—from early descriptions to modern genetics—has made earlier diagnosis and lifelong treatment more effective, giving many people with Wilson disease the chance to live full, active lives.